CD44v6
Showing 1 - 25 of >10,000
Acute Myeloid Leukemia, Multiple Myeloma Trial in Ostrava, Milan, Roma (MLM-CAR44.1 T-cells at day 0 Single intravenous
Terminated
- Acute Myeloid Leukemia
- Multiple Myeloma
- MLM-CAR44.1 T-cells at day 0 Single intravenous infusion
-
Ostrava, Czech Republic, Czechia
- +2 more
Dec 20, 2021
Cancers Which Are CD44v6 Positive Trial in Shenzhen (CD44v6-specific CAR gene-engineered T cells)
Recruiting
- Cancers Which Are CD44v6 Positive
- CD44v6-specific CAR gene-engineered T cells
-
Shenzhen, Guangdong, China
- +3 more
Jun 9, 2020
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in
Not yet recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +14 more
- Biopsy
- +25 more
-
Portland, OregonOHSU Knight Cancer Institute
Jul 12, 2022
Leukemia, Lymphoma Trial in Canada, United States (Patient-derived CD19- and CD22 specific CAR)
Recruiting
- Leukemia
- Lymphoma
- Patient-derived CD19- and CD22 specific CAR
-
Los Angeles, California
- +4 more
Apr 2, 2022
Metastatic Colorectal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v7 Trial in
Recruiting
- Metastatic Colorectal Adenocarcinoma
- +5 more
- Imiquimod
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Aug 26, 2022
Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia Trial in Vancouver, Ottawa (CLIC-1901)
Recruiting
- Acute Lymphoblastic Leukemia
- +2 more
- CLIC-1901
-
Vancouver, British Columbia, Canada
- +1 more
Mar 26, 2022
Advanced Colorectal Carcinoma, Metastatic Colon Adenocarcinoma, Metastatic Rectal Adenocarcinoma Trial in United States
Recruiting
- Advanced Colorectal Carcinoma
- +26 more
- Irinotecan
- +2 more
-
Tampa, Florida
- +3 more
Jun 22, 2022
Metastatic Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in Houston (biological, drug, other)
Active, not recruiting
- Metastatic Melanoma
- Stage IV Cutaneous Melanoma AJCC v6 and v7
- Aldesleukin
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Feb 2, 2022
Brodalumab in Plaque Psoriasis to Understand Impact on Quality
Recruiting
- Psoriasis
- Brodalumab
- Matched cohort
-
Calgary, Alberta, Canada
- +33 more
Oct 8, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Duarte
Recruiting
- Castration-Resistant Prostate Carcinoma
- +4 more
- Autologous Anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T-lymphocytes
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 17, 2022
Allergic Rhinitis Due to Dermatophagoides Farinae, Allergic Rhinitis Due to Dermatophagoides Pteronyssinus, Allergic Rhinitis
Active, not recruiting
- Allergic Rhinitis Due to Dermatophagoides Farinae
- +2 more
- Sublingual allergy immunotherapy tablet
- Placebo
-
Bakersfield, California
- +116 more
Dec 8, 2022
Dissecting the Biology of Early-onset Colorectal Cancer
Not yet recruiting
- Colon Cancer
- (no location specified)
Jun 14, 2023
Crohn Disease Trial in Worldwide (BI 706321, ustekinumab, Placebo)
Recruiting
- Crohn Disease
- BI 706321
- +2 more
-
Northridge, California
- +30 more
Aug 2, 2022
Lymphoma, Large B-Cell, Diffuse (DLBCL) Trial in Jerusalem, Seoul, Warszawa (Zilovertamab Vedotin, Cyclophosphamide,
Recruiting
- Lymphoma, Large B-Cell, Diffuse (DLBCL)
- Zilovertamab Vedotin
- +6 more
-
Victoria, British Columbia, Canada
- +19 more
Jan 19, 2023
Disease Activity and Adverse Events In Adult Moderate to Severe
Recruiting
- Crohn's Disease
-
Calgary, Alberta, Canada
- +48 more
Apr 24, 2023
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia Trial in Worldwide (radiation, biological, drug)
Suspended
- Down Syndrome
- Recurrent B Acute Lymphoblastic Leukemia
- 3-Dimensional Conformal Radiation Therapy
- +13 more
-
Birmingham, Alabama
- +202 more
Jan 17, 2023
Clostridium Difficile Infection, Infection, Communicable Diseases Trial in Canada, United States (RBX2660)
Active, not recruiting
- Clostridium Difficile Infection
- +2 more
-
Phoenix, Arizona
- +50 more
Jan 11, 2023
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma, Down Syndrome Trial in Worldwide (drug, biological, radiation)
Recruiting
- B Acute Lymphoblastic Leukemia
- +2 more
- Asparaginase Erwinia chrysanthemi
- +15 more
-
Birmingham, Alabama
- +219 more
Aug 24, 2022
Scalp Psoriasis Trial in Canada, United States (ARQ-154 Foam 0.3%, ARQ-154 Vehicle)
Completed
- Scalp Psoriasis
- ARQ-154 Foam 0.3%
- ARQ-154 Vehicle
-
Scottsdale, Arizona
- +48 more
Aug 4, 2022
